Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitors
摘要:
Benzoylisoindolines were discovered as a novel structural class of GlyT1 inhibitors. SAR studies and subsequent lead optimization efforts focused primarily on addressing hERG liability and on improving in vivo efficacy resulted in the identification of potent GlyT1 inhibitors displaying excellent selectivity and in vivo PD and PK profiles. (C) 2010 Elsevier Ltd. All rights reserved.
The present invention relates to compounds of formula I
wherein
R
1
,
R
2
, and
are defined in the specification
and to pharmaceutically acceptable acid addition salts thereof.